"Antilymphocyte Serum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
| Descriptor ID |
D000961
|
| MeSH Number(s) |
A12.207.152.846.500.203 D12.776.124.486.485.114.573.203 D12.776.124.790.651.114.573.203 D12.776.377.715.548.114.573.203 D20.215.401.203
|
| Concept/Terms |
Antilymphocyte Serum- Antilymphocyte Serum
- Antilymphocyte Serums
- Serum, Antilymphocyte
- Serums, Antilymphocyte
Antilymphocyte Globulin- Antilymphocyte Globulin
- Antilymphocyte Globulins
- Globulin, Antilymphocyte
- Globulins, Antilymphocyte
Antithymoglobulin- Antithymoglobulin
- Antithymoglobulins
- Antithymocyte Globulin
- Antithymocyte Globulins
- Globulin, Antithymocyte
- Globulins, Antithymocyte
- Lymphocyte Immune Globulin, Anti-Thymocyte Globulin
- Lymphocyte Immune Globulin, Anti Thymocyte Globulin
- Anti-Thymocyte Globulin
- Anti Thymocyte Globulin
- Anti-Thymocyte Globulins
- Globulin, Anti-Thymocyte
- Globulins, Anti-Thymocyte
Antilymphoblast Globulins- Antilymphoblast Globulins
- Antilymphoblast Globulin
- Globulin, Antilymphoblast
- Globulins, Antilymphoblast
Antilymphocyte Immunoglobulin- Antilymphocyte Immunoglobulin
- Antilymphocyte Immunoglobulins
- Immunoglobulin, Antilymphocyte
- Immunoglobulins, Antilymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Antilymphocyte Serum".
Below are MeSH descriptors whose meaning is more specific than "Antilymphocyte Serum".
This graph shows the total number of publications written about "Antilymphocyte Serum" by people in this website by year, and whether "Antilymphocyte Serum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 2 | 4 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 1 | 4 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antilymphocyte Serum" by people in Profiles.
-
Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT. Transplant Cell Ther. 2025 Jan; 31(1):18.e1-18.e12.
-
Outcomes after anti-thymocyte globulin vs Basiliximab induction before deceased donor kidney transplants. Transpl Immunol. 2022 12; 75:101733.
-
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin. Ann Hematol. 2021 Mar; 100(3):743-752.
-
Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab. Transpl Infect Dis. 2020 Jun; 22(3):e13257.
-
PTCY keeps on giving! Blood. 2019 09 12; 134(11):848-849.
-
Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study. Haematologica. 2019 10; 104(10):1974-1983.
-
A case of reversible cerebral vasoconstriction syndrome developing during treatment of adult aplastic anemia. Ann Hematol. 2019 Feb; 98(2):511-513.
-
T-cell depletion effects of low-dose antithymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation. Transpl Immunol. 2018 02; 46:21-22.
-
Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction. Transpl Infect Dis. 2017 Oct; 19(5).
-
Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction. Transpl Int. 2016 Aug; 29(8):897-908.